v3.26.1
Other Financial Assets
 12 Months Ended
Mar. 31, 2026
Subclassifications of assets, liabilities and equities [abstract]  
Other Financial Assets Other Financial Assets
JPY (millions)
As of March 31
20252026
Derivative financial instruments (Note 26)
¥84,369 ¥167,920 
Investments in convertible notes (Note 26)
10,424 8,776 
Investments in debt instruments (Note 26)
91,348 106,366 
Investments in equity instruments (Note 26)
151,687 173,034 
Financial assets associated with contingent consideration arrangements (Note 26)
10,197 10,488 
Other23,576 15,244 
Total¥371,600 ¥481,829 
Non-current¥351,124 ¥439,941 
Current¥20,476 ¥41,888 
As of March 31, 2025 and 2026, investments in equity instruments included JPY 78,073 million and JPY 106,729 million, respectively, of investments in public companies. These are considered Level 1 in the fair value hierarchy as defined in Note 26. The remainder of the equity instruments primarily relates to investments acquired in connection with collaborations and licensing agreements (Note 13) and are considered Level 3 investments in the fair value hierarchy.
As of March 31, 2025 and 2026, financial assets associated with contingent consideration arrangements are assets mainly recognized in relation to the divestiture of XIIDRA (Note 26) and are considered Level 3 investments in the fair value hierarchy.